STUDY SEARCH RESULTS

1 study found for your search request:  V503-049

Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillom...
Condition: Papillomavirus Infections
Minimum Age: 20 years, Maximum Age: 45 years
Gender: Male
Study ID: NCT04199689
Status: Active, not recruiting




Copyright © 2024 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  U.S. Corporate Site